The lower anogenital squamous terminology standardization project for hpv-associated lesions: Background and consensus recommendations from the college of american pathologists and the american society for colposcopy and cervical pathology

Journal of Lower Genital Tract Disease

Volumn 16, Issue 3, 2012, Pages 205-242

  Darragh, Teresa M ^a   Colgan, Terence J ^b   Cox, J Thomas ^c   Heller, Debra S ^c   Henry, Michael R ^d   Luff, Ronald D ^e,f   McCalmont, Timothy ^a   Nayar, Ritu ^g   Palefsky, Joel M ^a   Stoler, Mark H ^h   Wilkinson, Edward J ⁱ   Zaino, Richard J ^j   Wilbur, David C ^k  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d MAYO CLINIC   (United States)

^e QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^j PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

human papillomavirus; p16; squamous intraepithelial lesion; superficially invasive carcinoma; terminology

Indexed keywords

BIOLOGICAL MARKER;

ANAL CANAL; ARTICLE; BOWENOID PAPULOSIS; CANCER INVASION; CARCINOMA IN SITU; COLPOSCOPY; CONDYLOMA ACUMINATUM; CONSENSUS; CRYOTHERAPY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS ASSOCIATED ANOGENITAL LESION; HYSTERECTOMY; MITOSIS; NOMENCLATURE; PAPILLOMAVIRUS INFECTION; PATHOGENESIS; PATHOLOGIST; PENIS; SCROTUM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX DISEASE; VAGINA; VULVA;

ANAL CANAL; CARCINOMA, SQUAMOUS CELL; COLPOSCOPY; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES AS TOPIC; PRECANCEROUS CONDITIONS; REFERENCE STANDARDS; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VAGINAL SMEARS; VULVA;

EID: 84863604262     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31825c31dd     Document Type: Article

References (180)

1. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers 2007;23:297-313.
2. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32(suppl 1):S7YS15.
3. Stoler MH. The pathology of cervical neoplasia. In: Rohan TE, Shah KV, eds. Cervical Cancer: From Etiology to revention. New York, NY: Springer; 2004:3-60.
4. Stoler MH. Human papillomaviruses and cervical neoplasia: A model for carcinogenesis. Int J Gynecol Pathol 2000;19:16-28.
5. Solomon D, Davey D, Kurman R, Moriarty A, O'connor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
6. Stoler MH, Vichnin MD, Ferenczy A, Ferris DG, Perez G, Paavonen J, et al. The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011;128:1354-62.
7. Gage JC, HansonVW, Abbey K, Dippery S, Gardner S, Kubota J, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-72.
8. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004;191:430-4.
9. Pretorius RG, Belinson JL, Burchette RJ, Hu S, Zhang X, Qiao YL. Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. J Low Genit Tract Dis 2011;15:180-8.
10. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL triage study. JAMA 2001;285: 1500-5.
11. Mccredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol 2008;9:425-34.
12. Mccredie MR, Paul C, Sharples KJ, Baranyai J, Medley G, Skegg DC, et al. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. Aust N Z J Obstet Gynaecol 2010;50:363-70.
13. Jones RW. Vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2001;46 408.
14. Jones RW. Vulval intraepithelial neoplasia: Current perspectives. Eur J Gynaecol Oncol 2001;22:393-402.
15. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-Analysis. Lancet Oncol 2012;13:487-500.
16. Williams J.On Cancer of theUterus Being the Harveian Lectures for 1886. London, UK: H. K. Lewis; 1888.
17. Cullen TS. Cancer of the Uterus: Its Pathology, Symptomatology, Diagnosis, and Treatment. New York, NY: Appleton; 1900.
18. Rubin IC. The pathological diagnosis of incipient carcinoma of the cervix. Am J Obstet Gynecol 1910;62:668-76.
19. Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 1932;99:1670-4.
20. ReaganJW, HicksDJ.A study of in situ and squamouscell cancer of the uterine cervix. Cancer 1953;6:1200-14.
21. Reagan JW, Seidemann IL, Saracusa Y. The cellular morphology of carcinoma in situ and dysplasia or atypical hyperplasia of the uterine cervix. Cancer 1953;6:224-34.
22. Mckelvey JL. Carcinoma in situ of the cervix: A general consideration. Am J Obstet Gynecol 1952;64:816-32.
23. Hoffman J, Farell DM, Hahn GA. Review of 4,152 biopsies of the cervix with relation to carcinoma in situ. JAMA 1953;151:535-40.
24. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: Cytologic and pathologic study of koilocytotic atypia. Ann N Y Acad Sci 1956;63:1245-61.
25. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol 1976; 20:505-9.
26. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969;105: 386-93.
27. Koss LG. Dysplasia. A real concept or a misnomer? Obstet Gynecol 1978;51:374-9.
28. Robertson AJ, Anderson JM, Beck JS, Burnett RA, Howatson SR, Lee FD, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989;42:231-8.
29. Ismail SM, Colclough AB, Dinnen JS, Eakins D, Evans DM, Gradwell E, et al. Reporting cervical intraepithelial neoplasia (CIN): Intra- and interpathologist variation and factors associated with disagreement. Histopathology 1990;16:371-6.
30. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990;75:131-3.
31. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989;262:931-4.
32. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
33. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197: 340-5.
34. Heatley MK. How should we grade CIN? Histopathology 2002;40:377-90.
35. Crum CP. Symposium Part 1. Should the Bethesda System terminology be used in diagnostic surgical pathology?: Point. Int J Gynecol Pathol 2003;22:5-12.
36. Schneider V. Symposium Part 2. Should the Bethesda System terminology be used in diagnostic surgical pathology?: Counterpoint. Int J Gynecol Pathol 2003;22:13-7.
37. Herbert A, Arbyn M, Bergeron C. Why CIN3 and CIN2 should be distinguished on histological reports. Cytopathology 2008;19:63-4.
38. Boonlikit S, Srisantiroj N. Is there any clinical advantage in separating CIN2 from CIN3 in the current two-tiered cytological classification? Asian Pac J Cancer Prev 2009;10: 115-8.
39. Bellino R, Wierdis T, Arisio R, Re A, Tessarolo M, Leo L, et al. Microinvasive carcinoma of the uterine cervix. Diagnostic and therapeutic dilemma. Eur J Gynaecol Oncol 1994;15:380-5.
40. Woodruff JD. Carcinoma in situ of the vagina. Clin Obstet Gynecol 1981;24:485-501.
41. Mccartney AJ. Surgery of intraepithelial neoplasia, CIN, VaIN, and VIN. Baillieres Clin Obstet Gynaecol 1987;1: 447-84.
42. Turell R. Epidermoid squamous cell cancer of the perianus and anal canal. Surg Clin North Am1962;42: 1235-41.
43. Oriel JD, Whimster IW. Carcinoma in situ associated with virus-containing anal warts. Br J Dermatol 1971;84:71-3.
44. Durst M, Gissmann L, Ikenberg H, ZurHausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983;80:3812-5.
45. lARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer; 1995.
46. Fenger C, Bichel P. Flow cytometric DNA analysis of anal canal epithelium and ano-rectal tumours. Acta Pathol Microbiol Scand A 1981;89:351-5.
47. Fenger C, Nielsen VT. Intraepithelial neoplasia in the anal canal. The appearance and relation to genital neoplasia. Acta Pathol Microbiol Scand A 1986;94:343-9.
48. Northfelt DW, Swift PS, Palefsky JM. Anal neoplasia. Pathogenesis, diagnosis, and management. Hematol Oncol Clin North Am 1996;10:1177-87.
49. Rickert RR, Compton CC. Protocol for the examination of specimens from patients with carcinomas of the anus and anal canal: A basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 2000;124:21-5.
50. Wendell-Smith CP. Anorectal nomenclature: Fundamental terminology. Dis Colon Rectum 2000;43:1349-58.
51. Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: Analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009; 52:624-31.
52. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. NewYork, NY: Springer; 2010.
53. Bowen JT. Precancerous dermatoses: A study of two cases of chronic atypical epithelial proliferation. J Cutan Dis Syph 1912;30:241-55.
54. Woodruff JD, Hildebrandt EE. Carcinoma in situ of the vulva. Obstet Gynecol 1958;12:414-24.
55. Abell MR, Gosling JR. Intraepithelial and infiltrative carcinoma of vulva: Bowen's type. Cancer 1961;14: 318-29.
56. Friedrich EG Jr. Reversible vulvar atypia. A case report. Obstet Gynecol 1972;39:173-81.
57. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the penis. Cancer 1978;42:1890-903.
58. Friedrich EG Jr. New nomenclature for vulvar disease: Report of the committee on terminology. Obstet Gynecol 1976; 47:122-4.
59. Crum CP, Fu YS, Levine RU, Richart RM, Townsend DE, Fenoglio CM. Intraepithelial squamous lesions of the vulva: Biologic and histologic criteria for the distinction of condylomas from vulvar intraepithelial neoplasia. Am J Obstet Gynecol 1982;144:77-83.
60. Wilkinson EJ, Kneale B, Lynch PJ. Report of the ISSVD terminology committee. J Reprod Med 1986;31:973-4.
61. Scully RE, Poulsen HE. Histological Typing of Female Genital Tract Tumours. 2nd ed. Berlin, Germany: Springer-Verlag; 1994.
62. Gross G, Ikenberg H, Gissmann L, Hagedorn M. Papillomavirus infection of the anogenital region: Correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol 1985;85:147-52.
63. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD vulvar oncology subcommittee. J ReprodMed 2005;50:807-10.
64. Kurman RJ, Ronnett J, Sherman ME, Wilkinson EJ. Atlas of Tumor Pathology: Tumors of the Cervix, Vagina, and Vulva. Washington, DC: Armed Forces Institute of Pathology, American Registry of Pathology; 2010.
65. Barclay DL, Collins CG. Intraepithelial cancer of the vulva. Am J Obstet Gynecol 1963;86:95-106.
66. Kaufman RH. Intraepithelial carcinoma of the vulva. Obstet Gynecol Annu 1977;6:317-39.
67. Committee on Gynecologic Practice of American College Obstetricians and Gynecologists. ACOG Committee Opinion No. 509: Management of vulvar intraepithelial neoplasia. Obstet Gynecol 2011;118:1192-4.
68. Sulzberger MB, Satenstein DL. Erythroplasia of Queyrat. AMA Arch Derm Syphilol 1933;28:798-806.
69. Della Torre G, Donghi R, Longoni A, Pilotti S, Pasquini G, De Palo G, et al. HPV DNA in intraepithelial neoplasia and carcinoma of the vulva and penis. Diagn Mol Pathol 1992;1:25-30.
70. Cubilla AL, Reuter V, Velazquez E, Piris A, Saito S, Young RH. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. Int J Surg Pathol 2001;9:111-20.
71. Epstein J, Cubilla AL. Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum.Washington, DC: Armed Forces Institute of Pathology, American Registry of Pathology; 2011.
72. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 99: Management of abnormal cervical cytology and histology. Obstet Gynecol 2008;112: 1419-44.
73. Heller DS. Report of a new ISSVD classification of VIN. J Low Genit Tract Dis 2007;11:46-7.
74. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis 2006;10:161-9.
75. Castle PE, Stoler MH, Solomon D, Schiffman M. The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathologyreviewed diagnoses: An ALTS report. Am J Clin Pathol 2007; 127:805-15.
76. Witkiewicz AK,Wright TC, Ferenczy A, Ronnett BM, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, Ellenson LH, Ronnett BM, eds. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York, NY: Springer; 2011.
77. Crum CP, Lee KR. Diagnostic Gynecologic and Obstetric Pathology. Philadelphia, PA: Saunders; 2005.
78. Tabbara S, Saleh AD, Andersen WA, Barber SR, Taylor PT, Crum CP. The Bethesda classification for squamous intraepithelial lesions: Histologic, cytologic, and viral correlates. Obstet Gynecol 1992;79:338-46.
79. Genest DR, Stein L, Cibas E, Sheets E, Zitz JC, Crum CP. A binary (Bethesda) system for classifying cervical cancer precursors: Criteria, reproducibility, and viral correlates. Hum Pathol 1993;24:730-6.
80. Mccluggage WG, Walsh MY, Thornton CM, Hamilton PW, Date A, Caughley LM, et al. Inter- and intraobserver variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol 1998;105:206-10.
81. Mccluggage WG, Bharucha H, Caughley LM, Date A, Hamilton PW, Thornton CM, et al. Interobserver variation in the reporting of cervical colposcopic biopsy specimens: Comparison of grading systems. J Clin Pathol 1996;49:833-5.
82. Creagh T, Bridger JE, Kupek E, Fish DE, Martin-Bates E, Wilkins MJ. Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia. J Clin Pathol. 1995;48:59-60.
83. Lie AK, Skjeldestad FE, Hagen B, Haugen OA. Occurrence of human papillomavirus infection in cervical intraepithelial neoplasia. A retrospective histopathological study of 317 cases treated by laser conization. APMIS 1995; 103:693-8.
84. De Vet HC, Knipschild PG, Schouten HJ, Koudstaal J, Kwee WS, Willebrand D, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 1990;43:1395-8.
85. Kato I, Santamaria M, De Ruiz PA, Aristizabal N, Bosch FX, De Sanjose S, et al. Inter-observer variation in cytological and histological diagnoses of cervical neoplasia and its epidemiologic implication. J Clin Epidemiol 1995;48:1167-74.
86. Preti M, Mezzetti M, Robertson C, Sideri M. Interobserver variation in histopathological diagnosis and grading of vulvar intraepithelial neoplasia: Results of an European collaborative study. Br J Obstet Gynaecol 2000;107:594-9.
87. Lytwyn A, Salit IE, Raboud J, ChapmanW, Darragh T, Winkler B, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103:1447-56.
88. DijkstraMG, HeidemanDA, De Roy SC, Rozendaal L, Berkhof J, Van Krimpen K, et al. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 2010;63:972-7.
89. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
90. Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2010;133:395-406.
91. Horn LC, Reichert A, Oster A, Arndal SF, Trunk MJ, Ridder R, et al. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2008;32:502-12.
92. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda workshop. J Reprod Med 1992;37:383-6.
93. Parkin DM, Bray F. Chapter 2: The burden of HPVrelated cancers. Vaccine 2006;24(suppl 3):S11YS25.
94. Roche WD, Norris HJ. Microinvasive carcinoma of the cervix. The significance of lymphatic invasion and confluent patterns of stromal growth. Cancer 1975;36:180-6.
95. Chitale AR, Bhuvaneshwari AP, Khilnani P, Purandare VN. Pathology of microinvasive (stage 1 A) carcinoma of uterine cervix. Indian J Cancer 1977;14:189-94.
96. Gurgel MS, Bedone AJ, Andrade LA, Panetta K. Microinvasive carcinoma of the uterine cervix: Histological findings on cone specimens related to residual neoplasia on hysterectomy. Gynecol Oncol 1997;65:437-40.
97. Creasman WT, Fetter BF, Clarke-Pearson DL, Kaufmann L, Parker RT. Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-72.
98. Greer BE, Figge DC, Tamimi HK, Cain JM, Lee RB. Stage IA2 squamous carcinoma of the cervix: Difficult diagnosis and therapeutic dilemma. Am J Obstet Gynecol 1990;162: 1406-9; discussion 1409-11.
99. Zheng W, Robboy SJ. Cervical squamous cell carcinoma. In: Robboy SJ, Mutter GL, Prat J, Bentley R, Russell P, eds. Robboy's Pathology of the Female Reproductive Tract. 2nd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2008:227-48.
100. Andersen ES, Husth M, Joergensen A, Nielsen K. Laser conization for microinvasive carcinoma of the cervix. Short-term results. Int J Gynecol Cancer 1993;3:183-5.
101. Simon NL, Gore H, Shingleton HM, Soong SJ, Orr JW Jr, Hatch KD. Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986;68:19-24.
102. Hopkins MP, Morley GW. Microinvasive squamous cell carcinoma of the cervix. J Reprod Med 1994;39:671-3.
103. Raspagliesi F, Ditto A, Solima E, Quattrone P, Fontanelli R, Zanaboni F, et al. Microinvasive squamous cell cervical carcinoma. Crit Rev Oncol Hematol 2003;48:251-61.
104. Seski JC, Abell MR, Morley GW. Microinvasive squamous carcinoma of the cervix: Definition, histologic analysis, late results of treatment. Obstet Gynecol 1977;50:410-4.
105. Ostor AG, Rome RM. Micro-invasive squamous cell carcinoma of the cervix: A clinico-pathologic study of 200 cases with long-termfollow-up. Int J Gynecol Cancer 1994;4:257-64.
106. Sevin BU. Management of microinvasive cervical cancers. Semin Surg Oncol 1999;16:228-31.
107. Ayhan A, Tuncer ZS, Koseoglu F, Yuce K, Kucukali T. Microinvasive carcinoma of the cervix: An analysis of 31 patients. Eur J Gynaecol Oncol 1997;18:127-9.
108. Hasumi K, Sakamoto A, Sugano H. Microinvasive carcinoma of the uterine cervix. Cancer 1980;45:928-31.
109. Trelford JD, Tesluk H, Franti CE, Bradfield G, Ordorica E, Deer D. 20 year follow-up on microinvasive squamous carcinoma of the cervix. Eur J Gynaecol Oncol 1992;13:155-9.
110. Copeland LJ, Silva EG, Gershenson DM, Morris M, Young DC, Wharton JT. Superficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992;45:307-12.
111. Benedet JL, Anderson GH. Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996;87:1052-9.
112. Sedlis A, Sall S, Tsukada Y, Park R, Mangan C, Shingleton H, et al. Microinvasive carcinoma of the uterine cervix: A clinical-pathologic study. Am J Obstet Gynecol 1979; 133:64-74.
113. Averette HE, Nelson JH, Ng AB, Hoskins WJ, Boyce JG, Ford JH. Diagnosis and management of microinvasive (stage IA) carcinoma of the uterine cervix. Cancer 1976;38: 414-25.
114. Burghardt E. Microinvasive carcinoma in gynaecological pathology. Clin Obstet Gynaecol 1984;11:239-57.
115. Burghardt E, Girardi F, Lahousen M, Pickel H, Tamussino K. Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics stage IA). Cancer 1991;67:1037-45.
116. Witkiewicz A, Lee KR, Brodsky G, Cviko A, Brodsky J, Crum CP. Superficial (early) endocervical adenocarcinoma in situ: A study of 12 cases and comparison to conventional AIS. Am J Surg Pathol 2005;29:1609-14.
117. Kalof KN, Dadmanesh F, Longacre TA, Nucci MR, Oliva E, Cooper K. Protocol for the examination of specimens from patients with carcinoma of the uterine cervix. Available at http://www.cap.org/apps/docs/committees/cancer/cancer- protocols/2011/Cervix-11protocol.pdf. Accessed April 10, 2012.
118. Ostor AG, Mulvany N. The pathology of cervical neoplasia. Curr Opin Obstet Gynecol 1996;8:69-73.
119. Benedet JL. Cervical cancer staging systems: The endless debate. Gynecol Oncol 1997;65:6-7.
120. Ostor AG. Studies on 200 cases of early squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1993;12: 193-207.
121. Lee SW, Kim Y-M, Son W-S, You H-J, Kim D-Y, Kim J-H, et al. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand 2009;88:209-15.
122. Leman MH, Benson WL, Kurman RJ, Park RC. Microinvasive carcinoma of the cervix. Obstet Gynecol 1976;48:571-8.
123. Robert ME, Fu YS. Squamous cell carcinoma of the uterine cervixVa review with emphasis on prognostic factors and unusual variants. Semin Diagn Pathol 1990;7:173-89.
124. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Cancer 2009;105:103-4.
125. Pecorelli S, Odicino F. Cervical cancer staging. Cancer J 2003;9:390-4.
126. Yamaguchi H, Ueda M, Kanemura M, Izuma S, Nishiyama K, Tanaka Y, et al. Clinical efficacy of conservative laser therapy for early-stage cervical cancer. Int J Gynecol Cancer 2007;17:455-9.
127. Andersen ES, Nielsen K, Pedersen B. Combination laser conization as treatment of microinvasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 1998;19:352-5.
128. Elliott P, Coppleson M, Russell P, Liouros P, Carter J, Macleod C, et al. Early invasive (FIGO stage IA) carcinoma of the cervix: A clinico-pathologic study of 476 cases. Int J Gynecol Cancer 2000;10:42-52.
129. Kolstad P. Follow-up study of 232 patients with stage IA1 and 411 patients with stage IA2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 1989; 33:265-72.
130. Creasman WT, Weed JC. Microinvasive cancer vs occult cancer. Int J Radiat Oncol Biol Phys 1979;5:1871-2.
131. Schink JC, Lurain JR. Microinvasive cervix cancer. Int J Gynaecol Obstet 1991;36:5-11.
132. Duncan ID, Walker J. Microinvasive squamous carcinoma of cervix in the Tayside region of Scotland. Br J Obstet Gynaecol 1977;84:67-70.
133. Orlandi C, Costa S, Terzano P, Martinelli GN, Comerci G, Guerra B, et al. Presurgical assessment and therapy of microinvasive carcinoma of the cervix. Gynecol Oncol 1995;59:255-60.
134. Mota F. Microinvasive squamous carcinoma of the cervix: Treatment modalities. Acta Obstet Gynecol Scand 2003; 82:505-9.
135. Buckley SL, Tritz DM, Van Le L, Higgins R, Sevin BU, Ueland FR, et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996; 63:4-9.
136. Van Nagell JR, Greenwell N, PowellDF, Donaldson ES, Hanson MB, Gay EC. Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1983;145:981-91.
137. Costa S, Marra E,MartinelliGN, Santini D, Casadio P, Formelli G, et al. Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up. Int J Gynecol Cancer 2009;19:33-8.
138. Kodama J, Mizutani Y, Hongo A, Yoshinouchi M, Kudo T, Okuda H. Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix. Eur J Obstet Gynecol Reprod Biol 2002;101:192-5.
139. Kim WY, Chang S-J, Chang K-H, Yoo S-C, Ryu H-S. Conservative management of stage IA1 squamous cell carcinoma of the cervix with positive resection margins after conization. Int J Gynaecol Obstet 2010;109:110-2.
140. Marana HR, De Andrade JM, Matthes AC, Spina LA, Carrara HH, Bighetti S. Microinvasive carcinoma of the cervix. Analysis of prognostic factors. Eur J Gynaecol Oncol 2001;22:64-6.
141. Lin H, Chang HY, Huang CC, Changchien CC. Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. Int J Gynecol Cancer 2004;14:311-6.
142. Phongnarisorn C, Srisomboon J, Khunamornpong S, Siriaungkul S, Suprasert P, Charoenkwan K, et al. The risk of residual neoplasia in women with microinvasive squamous cervical carcinoma and positive cone margins. Int J Gynecol Cancer 2006;16:655-9.
143. Jones WB, Mercer GO, Lewis JL, Rubin SC, Hoskins WJ. Early invasive carcinoma of the cervix. Gynecol Oncol 1993;51:26-32.
144. Peters WA, Kumar NB, Morley GW. Microinvasive carcinoma of the vagina: A distinct clinical entity? Am J Obstet Gynecol 1985;153:505-7.
145. Dini MM, Park JM. Microinvasive squamous cell carcinoma of the vagina. J Natl Med Assoc 1984;76:709-11.
146. Wilkinson EJ. Pathology of the vagina. Curr Opin Obstet Gynecol 1991;3:553-60.
147. Shia J. An update on tumors of the anal canal. Arch Pathol Lab Med 2010;134:1601-11.
148. Salmo E, Haboubi N. Anal cancer: Pathology, staging and evidence-based minimum data set. Colorectal Dis 2011; 13(suppl 1):11-20.
149. Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984;27:763-6.
150. Martin FT, Kavanagh D, Waldron R. Squamous cell carcinoma of the anal canal. Surgeon 2009;7:232-7.
151. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: The spectrum of disease, treatment, and outcomes. Cancer 1999;85:1686-93.
152. Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol 2008;15:263-78.
153. Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, et al. Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome. Dis Colon Rectum 2008;51:147-53.
154. Tantipalakorn C, Robertson G,MarsdenDE, GebskiV, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol 2009;113: 895-901.
155. Faught W, Jeffrey J, Bryson P, Dawson L, Helewa M, Kwon J, et al. Management of squamous cell cancer of the vulva. J Obstet Gynaecol Can 2006;28:640-51.
156. Preti M, Rouzier R, Mariani L, Wilkinson EJ. Superficially invasive carcinoma of the vulva: Diagnosis and treatment. Clin Obstet Gynecol 2005;48:862-8.
157. Maiche AG, Pyrhonen S. Clinical staging of cancer of the penis: By size? By localization? Or by depth of infiltration? Eur Urol 1990;18:16-22.
158. Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, et al. EAU Penile Cancer Guidelines 2009. Eur Urol 2010;57:1002-12.
159. Lowe FC. Squamous-cell carcinoma of the scrotum. Urol Clin North Am 1992;19:397-405.
160. Frisch M, Fenger C, Van Den Brule AJ, Sorensen P, Meijer CJ, Walboomers JM, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999;59:753-7.
161. Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 2004;13:263-75.
162. StolerMH. Toward objective cervical cancer screening: Maybe the eyes do have it. Am J Clin Pathol 2010;134:5-6.
163. Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 2010;34: 1077-87.
164. Santos M, Landolfi S, Olivella A, Lloveras B, Klaustermeier J, Suarez H, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006;30:1347-56.
165. Klaes R, Friedrich T, Spitkovsky D, Ridder R, RudyW, Petry U, et al. Overexpression of p16(INK4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
166. Tringler B, Gup CJ, Singh M, Groshong S, Shroyer AL, Heinz DE, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004;35:689-96.
167. Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Costa S, et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005;124:113-21.
168. Bernard JE, Butler MO, Sandweiss L, Weidner N. Anal intraepithelial neoplasia: Correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization. Appl Immunohistochem Mol Morphol 2008;16:215-20.
169. Riethdorf S, Neffen EF, Cviko A, Loning T, Crum CP, Riethdorf L. p16INK4a expression as biomarker for HPV 16Yrelated vulvar neoplasias. Hum Pathol 2004;35:1477-83.
170. Benevolo M, Terrenato I, Mottolese M, Marandino F, Muti P, Carosi M, et al. Comparative evaluation of nm23 and p16 expression as biomarkers of high-risk human papillomavirus infection and cervical intraepithelial neoplasia 2(+) lesions of the uterine cervix. Histopathology 2010;57:580-6.
171. Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006;19:384-91.
172. Negri G, Vittadello F, Romano F, Kasal A, Rivasi F, Girlando S, et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004;445:616-20.
173. Ozaki S, Zen Y, Inoue M. Biomarker expression in cervical intraepithelial neoplasia: Potential progression predictive factors for low-grade lesions. Hum Pathol 2011;42: 1007-12.
174. Del Pino M, Garcia S, Fuste V, Alonso I, Fuste P, Torne A, et al. Value of p16(INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1. Am J Obstet Gynecol 2009;201:488.e1-7.
175. Ordi J, Garcia S, Del Pino M, Landolfi S, Alonso I, Quinto L, et al. p16INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol 2009;28: 90-7.
176. Katki HA, Wacholder S, Solomon D, Castle PE, Schiffman M. Risk estimation for the next generation of prevention programmes for cervical cancer. Lancet Oncol 2009; 10:1022-3.
177. Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice. Lancet Oncol 2011;12:663-72.
178. Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL. High-risk human papillomavirus testing in women with ASC-US cytology: Results from the ATHENA HPV study. Am J Clin Pathol 2011;135:468-75.
179. Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. The ATHENA human papillomavirus study: Design, methods, and baseline results. Am J Obstet Gynecol 2012;206:46.e1-11.
180. College of American Pathologists. CAP laboratory accreditation checklists. Available at: Http://www.cap.org/apps/ cap.portal. Accessed April 11, 2012.